-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Propanc Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2011 to Q3 2025.
- Propanc Biopharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Sep 2025 was $2.53M, a 1071% increase year-over-year.
- Propanc Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $491K, a 47.9% decline from 2024.
- Propanc Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $942K, a 15.4% decline from 2023.
- Propanc Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1.11M, a 25.3% decline from 2022.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)